Treatment-free remission in Chronic Myeloid Leukemia harboring atypical BCR-ABL1 transcripts.

Treatment-free remission in Chronic Myeloid Leukemia harboring atypical BCR-ABL1 transcripts.

Discontinuation of tyrosine kinase inhibitors (TKI) is the main goal today in the field of Philadelphia positive chronic myeloid leukemia (Ph + CML) and the criteria to attempt the interruption of therapy are well defined and rely on the possibility to regularly monitor the BCR-ABL1 transcript. Pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Matteo Dragani, Jessica Petiti, Giovanna Rege-Cambrin, Enrico Gottardi, Filomena Daraio, Giovanni Caocci, Chiara Aguzzi, Elena Crisà, Giacomo Andreani, Francesca Caciolli, Carmen Fava
Format: Article
Language:English
Published: PAGEPress Publications 2020-08-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Online Access:https://www.mjhid.org/index.php/mjhid/article/view/4306
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items